TABLE 3.
Bivariate and Multivariable Analyses Associated With Coping Worse During Pandemic
| Variables | Bivariate | Initial Multivariablea | Final Multivariablea | ||||||
|---|---|---|---|---|---|---|---|---|---|
| OR | 95% Confidence Interval | p value | OR | 95% Confidence Interval | p value | OR | 95% Confidence Interval | p value | |
| More PROMIS-measured anxiety at follow-up compared with enrollment | 4.4 | 1.2–15.8 | 0.03 | 4.0 | 1.0–16.5 | 0.05 | 4.4 | 1.1–17.3 | 0.03 |
| Rheumatic disease more active or unpredictable during pandemic | 3.0 | 1.3–6.6 | 0.008 | 1.9 | 0.7–4.8 | 0.19 | — | — | — |
| Disease status at follow-up not excellent/very good | 2.6 | 1.2–6.0 | 0.02 | 2.2 | 0.9–5.7 | 0.10 | 2.7 | 1.1–6.5 | 0.03 |
| High overall stress during pandemic | 4.8 | 1.5–15.2 | 0.008 | 4.0 | 1.1–14.6 | 0.04 | 5.7 | 1.6–20.1 | 0.007 |
| Adverse effects on health during pandemic | 3.4 | 1.2–9.5 | 0.02 | 2.1 | 0.6–6.8 | 0.22 | 3.0 | 1.0–9.0 | 0.05 |
| Adverse effects on employment during pandemic | 3.9 | 1.3–11.5 | 0.01 | 5.4 | 1.6–18.2 | 0.007 | 6.1 | 1.9–20.0 | 0.003 |
| Started antidepressant/antianxiety medications during pandemic | 8.4 | 1.9–38.5 | 0.006 | 3.3 | 0.6–18.2 | 0.16 | — | — | — |
| Engaged in unhealthy behaviors during pandemic | 3.9 | 1.1–13.1 | 0.03 | 1.6 | 0.4–6.8 | 0.52 | — | — | — |
a Based on ordinal logistic regression models.